References
The problem of prisoner (re)entry. Contemp Sociol. 2006;35(6):562-565.
. Hepatitis C prevalence in incarcerated settings between 2013–2021: a systematic review and meta-analysis. BMC Public Health. 2022;22(1):2159.
. A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veterans. AIDS Res Hum Retroviruses. 2011;27(9):973-979.
. . Limited access to new hepatitis C virus treatment under state medicaid programs. Ann Intern Med. 2015;163(3):226-228.
. Sofosbuvir, velpatasvir, and voxilaprevir for treatment of recurrent hepatitis C virus infection after liver transplantation. Hepatol Commun. 2018;2(12):1446-1450.
. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet. 2019;393(10179):1453-1464. doi:10.1016/S0140-6736(18)32111-1.
. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology. 2004;39(1):90-96.
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343-350.
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol. 2010;52(2):191-198.
. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142(6):1293-1302.
. Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study. J Pediatr Gastroenterol Nutr. 2001;33(5):570-575.
Centers for Disease Control and Prevention (CDC). Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. 2001;50(RR-5):1-43.
Centers for Disease Control and Prevention (CDC). Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men--New York City, 2005-2010. MMWR Morb Mortal Wkly Rep. 2011;60(28):945-950.
US Centers for Disease Control and Prevention. Viral hepatitis surveillance—United States, 2017. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. Available at: https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm. Accessed May 26, 2021.
Centers for Disease Control and Prevention (CDC). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1-39.
Centers for Disease Control and Prevention (CDC). Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep. 2013;62(18):362-365.
Centers for Disease Control and Prevention (CDC). Viral hepatitis statistics and surveillance, hepatitis C. Updated 2016. 2016. Available at: https://www.cdc.gov/hepatitis/hcv/StatisticsHCV.htm. Accessed Accessed June 13, 2019.
Centers for Disease Control and Prevention (CDC). 2015 sexually transmitted diseases treatment guidelines, special populations.; 2015. Available at: https://www.cdc.gov/std/tg2015/specialpops.htm. Accessed June 8, 2021.